Amgen Aranesp, Vectibix Setbacks Illustrate Risks Of Real World Trials
Executive Summary
Amgen's failed Anemia of Cancer trial of Aranesp and Panitumumab Advanced Colorectal Cancer Evaluation (PACCE) trial of Vectibix may illustrate the potential pitfalls facing sponsors that conduct "real world" trials of their products